P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K Inhibitors
Raju Subramanian(Gilead Sciences (United States)), Hervé Lebrec(Amgen (United States)), Dan Branstetter(Amgen (United States)), Ronya Primack(Amgen (United States)), Nancy Everds(Amgen (United States)), Mark H. Norman(Amgen (United States)), Mylo Wagner(Amgen (United States)), Irene Soto(Amgen (United States)), Jian Jiang(Xuzhou Medical College), Divesh Aidasani(Amgen (United States)), Gary L. Skiles, Tian Wu(Guangzhou University of Chinese Medicine), Xiaochun Zhu(Amgen (United States)), Keith Bailey(Amgen (United States)), Markian M. Stec(Amgen (United States))
Cited by 7
Related Papers
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325
Comparison of Information-Dependent Acquisition, SWATH, and MS<sup>All</sup> Techniques in Metabolite Identification Study Employing Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry
|Analytical Chemistry|2013|211
Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry
|Journal of Mass Spectrometry|2006|153